Efficiency, Enhancing, Collaboration, Clinical, Trials, Clinical Innovation

Efficiency Enhancing Collaboration in Clinical Trials

At the 2014 Clinical Innovation Congress, Pete Milligan, TransCelerate Biopharma inc, gave a presentation on “Efficiency Enhancing Collaboration in Clinical Trials”. Download and learn: Collaboration Ongoing Initiatives Key Accomplishments to Date The future New Initiatives Download this presentation: Found this interesting? Join us at the 2nd annual Clinical Innovation Congress (formerly Disruptive Innovation in Clinical Trials).  The Congress will share insight …

Partnering, Success, Collaboration, Practice, Clinical, Trial, Efficiency, Clinical Outsourcing

Partnering for success: Collaboration and best practice for clinical trial efficiency

At the 2014 Clinical Outsourcing & Partnering World event, Bert Hartog, Janssen, gave a presentation on “Partnering for success Collaboration and best practice for clinical trial efficiency”. Hartog’s presentation discusses traditional outsourcing and current vision, as well as focusing on essentials for success such as strategic partnership based on shared goals and intelligent suppliers. Download and learn: Enabling a strategic partnership …

Download: Pharma-Payer Research Collaborations

At Evidence USA 2013, Rami Ben-Joseph, Head of Health Outcomes and Pharmacoeconomics, Purdue Pharma gave a presentation on “Pharma-Payer Research Collaborations” Download to learn: Healthcare paradigm shift Patients empowered by technology Payer research collaborations Stakeholder objectives Shared value via scientific dialogue and collaborative research Contributions Outcomes: Pharma Outcomes: Payer Download presentation Rami Ben- Joseph will be presentating at this year’s …

Download Commercializing through collaboration: what does partnering in the stem cells industry really look like?

Download this presentation here > The 9th World Stem Cells & Regenerative Medicine Congress is Europe’s leading scientific and business development event for the stem cell and cell therapy industry. At the 2013 event, delegates were fortunate enough to hear from Ed Field, Chief Operating Officer, Cytomedix who delivered the presentation: ‘Commercializing through collaboration: what does partnering in this industry really …

Bringing stem cell research to the market as commercial therapies

“There’s nothing like a live conference…you can set up both formal and informal meetings” – Keith Thompson, CEO, Cell Therapy Catapult Increased collaboration and lowering the barriers to finding investment are two of the most crucial goals for the global stem cell and regenerative medicine industry over the coming years if it is to translate cutting edge science into commercialised …

Europe’s reaction to CAVOMP’s harmonization in the orphan drugs space

There are conflicting opinions about CAVOMP and how far it will go with harmonizing reimbursement policies among the 27 countries in the EU. We need to remember that sovereignty issues to consider as well. Governments, the EMA, industry, payers and patients, all feel that more collaboration is necessary in order to align everyone's interests. It may also be necessary to …

Brinks: Avoiding ownership disputes in intellectual property collaborations

In the drive to identify new therapeutic technologies, the pharma industry is increasingly looking to form strategic collaborations with other members of the industry in order to mix creative ideas and technical insight. For a successful outcome, it is important that both parties have a clear understanding of what each party is to gain from the collaboration. Identifying ownership of …

How to grow your business within the stem cell and regenerative medicine industry

It is an exciting time to be part of the stem cell and regenerative medicine industry. In an industry that promises to transform healthcare and the lives of patients with poorly met medical need, cell therapy developers are jostling for position to lead this pioneering industry. The World Stem Cells & Regenerative Medicine Congress is a very strongly attended "one-stop …